A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Advances in Interventional Radiology in the Treatment of Primary and Metastatic Liver Cancer
2007
European Oncology & Haematology
Hepatocellular carcinoma (HCC), a primary malignancy of the hepatocyte, is increasing in incidence worldwide. Chronic liver damage is the most important risk factor. The incidence of HCC is directly related to that of hepatitis B and C infection, and cirrhosis is present in 80% of cases. 1 It is the fifth most common primary malignancy worldwide, and the third most common cause of cancer-related death. 2 In Europe, metastatic liver disease is much more common than HCC, with 30-70% (depending on
doi:10.17925/eoh.2007.0.2.68
fatcat:cphavzqmqndptgurleqv355ptm